Terms: = Leukemia AND NUP98, NUP196, 4928, ADIR2, ENSG00000110713
316 results:
1. [Clinical significance of monitoring nup98::NSD1 fusion genes before and after allogeneic hematopoietic stem cell transplantation].
Shang YK; Pan XA; Chang YJ; Qin YQ; Wang Y; Yan CH; Sun YQ; Huang XJ; Zhao XS
Zhonghua Xue Ye Xue Za Zhi; 2023 Dec; 44(12):1010-1015. PubMed ID: 38503524
[No Abstract] [Full Text] [Related]
2. Acute myeloid leukemia with rare recurring translocations-an overview of the entities included in the international consensus classification.
Rørvik SD; Torkildsen S; Bruserud Ø; Tvedt THA
Ann Hematol; 2024 Apr; 103(4):1103-1119. PubMed ID: 38443661
[TBL] [Abstract] [Full Text] [Related]
3. Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemia.
Abla O; Ries RE; Triche T; Gerbing RB; Hirsch B; Raimondi S; Cooper T; Farrar JE; Buteyn N; Harmon LM; Wen H; Deshpande AJ; Kolb EA; Gamis AS; Aplenc R; Alonzo T; Meshinchi S
Blood Adv; 2024 Apr; 8(8):2005-2017. PubMed ID: 38306602
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia.
Tarlock K; Gerbing RB; Ries RE; Smith JL; Leonti A; Huang BJ; Kirkey D; Robinson L; Peplinksi JH; Lange B; Cooper TM; Gamis AS; Kolb EA; Aplenc R; Pollard JA; Alonzo TA; Meshinchi S
Blood Adv; 2024 May; 8(9):2094-2103. PubMed ID: 38295280
[TBL] [Abstract] [Full Text] [Related]
5. NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions.
Nuñez Y; Vera S; Baeza V; Gonzalez-Pecchi V
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256018
[TBL] [Abstract] [Full Text] [Related]
6. Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression.
Juul-Dam KL; Shukla NN; Cooper TM; Cuglievan B; Heidenreich O; Kolb EA; Rasouli M; Hasle H; Zwaan CM
Eur J Med Genet; 2023 Dec; 66(12):104869. PubMed ID: 38174649
[TBL] [Abstract] [Full Text] [Related]
7. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
Hoffmeister LM; Suttorp J; Walter C; Antoniou E; Behrens YL; Göhring G; Awada A; von Neuhoff N; Reinhardt D; Schneider M
Leukemia; 2024 Mar; 38(3):538-544. PubMed ID: 38086945
[TBL] [Abstract] [Full Text] [Related]
8. Clinical whole-genome sequencing and FISH identify two different fusion partners for nup98 in a patient with acute myeloid leukemia: A case report.
Mojarad BA; Crees ZD; Schroeder MC; Xiang Z; Vader J; Sina J; Jacoby M; Frater JL; Duncavage EJ; Spencer DH; Lavine K; Neidich JA; Amarillo I
Cancer Genet; 2024 Jan; 280-281():1-5. PubMed ID: 38056049
[TBL] [Abstract] [Full Text] [Related]
9. The future of HOXA- expressing leukemias: Menin inhibitor response and resistance.
Wenge DV; Armstrong SA
Curr Opin Hematol; 2024 Mar; 31(2):64-70. PubMed ID: 38010951
[TBL] [Abstract] [Full Text] [Related]
10. Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors.
Barajas JM; Rasouli M; Umeda M; Hiltenbrand R; Abdelhamed S; Mohnani R; Arthur B; Westover T; Thomas ME; Ashtiani M; Janke LJ; Xu B; Chang TC; Rosikiewicz W; Xiong E; Rolle C; Low J; Krishan R; Song G; Walsh MP; Ma J; Rubnitz JE; Iacobucci I; Chen T; Krippner-Heidenreich A; Zwaan CM; Heidenreich O; Klco JM
Blood; 2024 Feb; 143(7):619-630. PubMed ID: 37890156
[TBL] [Abstract] [Full Text] [Related]
11. CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
Gress V; Roussy M; Boulianne L; Bilodeau M; Cardin S; El-Hachem N; Lisi V; Khakipoor B; Rouette A; Farah A; Théret L; Aubert L; Fatima F; Audemard É; Thibault P; Bonneil É; Chagraoui J; Laramée L; Gendron P; Jouan L; Jammali S; Paré B; Simpson SM; Tran TH; Duval M; Teira P; Bittencourt H; Santiago R; Barabé F; Sauvageau G; Smith MA; Hébert J; Roux PP; Gruber TA; Lavallée VP; Wilhelm BT; Cellot S
Blood Adv; 2024 Jan; 8(1):112-129. PubMed ID: 37729615
[TBL] [Abstract] [Full Text] [Related]
12. Phase-separated nuclear bodies of nucleoporin fusions promote condensation of MLL1/CRM1 and rearrangement of 3D genome structure.
Oka M; Otani M; Miyamoto Y; Oshima R; Adachi J; Tomonaga T; Asally M; Nagaoka Y; Tanaka K; Toyoda A; Ichikawa K; Morishita S; Isono K; Koseki H; Nakato R; Ohkawa Y; Yoneda Y
Cell Rep; 2023 Aug; 42(8):112884. PubMed ID: 37516964
[TBL] [Abstract] [Full Text] [Related]
13. Clinical implications of nup98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AML.
Miyajima T; Onozawa M; Yoshida S; Miyashita N; Kimura H; Takahashi S; Yokoyama S; Matsukawa T; Goto H; Sugita J; Fujisawa S; Hidaka D; Ogasawara R; Mori A; Matsuoka S; Shigematsu A; Wakasa K; Kasahara I; Saga T; Hashiguchi J; Takeda Y; Ibata M; Yutaka T; Fujimoto K; Kondo T; Teshima T
Eur J Haematol; 2023 Oct; 111(4):620-627. PubMed ID: 37465857
[TBL] [Abstract] [Full Text] [Related]
14. The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression.
Kfoury YS; Ji F; Jain E; Mazzola M; Schiroli G; Papazian A; Mercier F; Sykes DB; Kiem A; Randolph M; Calvi LM; Abdel-Wahab O; Sadreyev RI; Scadden DT
Blood Adv; 2023 Nov; 7(21):6608-6623. PubMed ID: 37450380
[TBL] [Abstract] [Full Text] [Related]
15. Acute myeloid leukemia with nup98::RARG resembling acute promyelocytic leukemia accompanying ARID1B gene mutation.
Wu D; Gao R
Hematology; 2023 Dec; 28(1):2227495. PubMed ID: 37387408
[TBL] [Abstract] [Full Text] [Related]
16. The pediatric leukemia oncoprotein nup98-KDM5A induces genomic instability that may facilitate malignant transformation.
Domingo-Reinés J; Montes R; Garcia-Moreno A; Gallardo A; Sanchez-Manas JM; Ellson I; Lamolda M; Calabro C; López-Escamez JA; Catalina P; Carmona-Sáez P; Real PJ; Landeira D; Ramos-Mejia V
Cell Death Dis; 2023 Jun; 14(6):357. PubMed ID: 37301844
[TBL] [Abstract] [Full Text] [Related]
17. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
[TBL] [Abstract] [Full Text] [Related]
18. ABL1 kinase as a tumor suppressor in AML1-ETO and nup98-PMX1 leukemias.
Golovine K; Abalakov G; Lian Z; Chatla S; Karami A; Chitrala KN; Madzo J; Nieborowska-Skorska M; Huang J; Skorski T
Blood Cancer J; 2023 Mar; 13(1):42. PubMed ID: 36959186
[TBL] [Abstract] [Full Text] [Related]
19. Identifying prognostic gene panels in acute myeloid leukemia.
Sanchez-Garcia J; Serrano J; Prados de La Torre E; Serrano-López J; Aparicio-Perez C; Barragán E; Montesinos P
Expert Rev Hematol; 2023 Apr; 16(4):277-287. PubMed ID: 36951195
[TBL] [Abstract] [Full Text] [Related]
20. Validation of the prognostic significance of the 2022 European leukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
Lo MY; Tsai XC; Lin CC; Tien FM; Kuo YY; Lee WH; Peng YL; Liu MC; Tseng MH; Hsu CA; Chen JC; Lin LI; Sun HI; Chuang YK; Ko BS; Tang JL; Yao M; Chou WC; Hou HA; Tien HF
Am J Hematol; 2023 May; 98(5):760-769. PubMed ID: 36861732
[TBL] [Abstract] [Full Text] [Related]
[Next]
